← back to search

Ali Choucair

Université Claude Bernard Lyon 1 · FR
Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research focused on Memantine and Radiation therapy, with related work in Placebo, Gefitinib, Glioma. Notable publications include 'Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial', 'RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients', and 'Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials'.
h-index
—
citations
1,359
works
6
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer
Oncogene 2019cited by 46position: firstdoi
LKB1 regulates PRMT5 activity in breast cancer
International Journal of Cancer 2018cited by 46position: middledoi
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials
Neuro-Oncology 2016cited by 128position: middledoi
Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
Neuro-Oncology 2013cited by 937position: middledoi
RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
International Journal of Radiation Oncology*Biology*Physics 2012cited by 170position: middledoi
Memantine for the Prevention of Cognitive Dysfunction in Patients Receiving Whole-brain Radiation Therapy (WBRT): First Report of RTOG 0614, a Placebo-controlled, Double-blind, Randomized Trial
International Journal of Radiation Oncology*Biology*Physics 2012cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Minesh P. Mehta · Carbon Engineering (Canada)3 papers (2012–2013)Deborah Watkins Bruner · Emory University2 papers (2012–2013)Olivier Trédan · Institut de Cancérologie de l'Ouest2 papers (2018–2019)Muriel Le Romancer · Université Claude Bernard Lyon 12 papers (2018–2019)David Roberge · Centre Hospitalier de l’Université de Montréal2 papers (2012–2013)Julien Jacquemetton · Université Claude Bernard Lyon 12 papers (2018–2019)Nadia N. Laack · Mayo Clinic2 papers (2012–2013)— · 2 papers (2012–2013)Isabelle Treilleux · Université Claude Bernard Lyon 12 papers (2018–2019)John H. Suh · Texas A&M University2 papers (2012–2013)— · 2 papers (2018–2019)Laura Corbo · Université Claude Bernard Lyon 12 papers (2018–2019)— · 1 papers (2016–2016)S. Pugh · Roswell Park Comprehensive Cancer Center1 papers (2013–2013)Jeffrey S. Wefel · The University of Texas MD Anderson Cancer Center1 papers (2013–2013)Christopher J. Schultz · University of North Carolina at Charlotte1 papers (2012–2012)Lisa M. DeAngelis · Universidad Católica de Santa Fe1 papers (2016–2016)— · 1 papers (2016–2016)Martin J. van den Bent · St James's University Hospital1 papers (2016–2016)Ryo Nishikawa · Nagoya Institute of Technology1 papers (2016–2016)